Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating safety, tolerability, pharmacokinetics and pharmacodynamics of MK-8655 in adults with Type 2 Diabetes; completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-8655 (MK-8655)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2018-11-13